Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
2022
1,338 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
171.59
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma | Researchclopedia
·
Khon Kaen University
Yoon‐Koo Kang
·
University of Ulsan
Tu Van Dao
·
National Hospital of Pediatrics
Enrico N. De Toni
·
Ludwig-Maximilians-Universität München
Lorenza Rimassa
·
Humanitas University
В. В. Бредер
·
Russian Cancer Research Center NN Blokhin
Alexander Vasilyev
·
Russian Railways
Alexandra Heurgué
·
Hôpital Robert-Debré
Vincent C. Tam
·
University of Calgary
Kabir Mody
·
Mayo Clinic in Florida
Satheesh Chiradoni Thungappa
·
Sri Venkateshwaraa Medical College Hospital and Research Centre
Yuriy Ostapenko
·
National Cancer Institute
Thomas Yau
·
Queen Mary Hospital
Sérgio Jobim Azevedo
·
Hospital de Clínicas de Porto Alegre
Marı́a Varela
·
Universidad de Oviedo
Ann‐Lii Cheng
·
National Taiwan University Hospital
Shukui Qin
·
81th Hospital of PLA
Peter R. Galle
·
Johannes Gutenberg University Mainz
Sajid Ali
·
AstraZeneca (Japan)
Michelle Marcovitz
·
AstraZeneca (Japan)
Mallory Makowsky
·
AstraZeneca (Japan)
Philip He
·
AstraZeneca (Japan)
John F. Kurland
·
AstraZeneca (Japan)
Alejandra Negro
·
AstraZeneca (Japan)
Bruno Sangro
·
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas